#AseBioInterview | This has been the development process of the first vaccine against Epiz... 17/07/2024 Healthcare Innovative drugs Agrifood Animal health "Currently, the outbreak of EHDV serotype 8 is generating great alarm due to its epidemic potential and the absence of a... AseBio - Zendal
AseBio values the call for grants aimed at the development of UiC positively but regrets t... 16/07/2024 Healthcare Access to innovation Financing We trust that the call will strengthen the country's clinical research capabilities, which will help consolidate Spain's... AseBio
New €1.3 million round for Viva in Vitro brings it over €3 million investment to fight sep... 09/07/2024 Healthcare Personalized medicine In less than 3 years, the Spanish biotech company has attracted the confidence of investors and international medical... Partners - VIVA IN VITRO
ORYZON receives “Decision to grant” for two important patents for vafidemstat in Japan 08/07/2024 Healthcare Innovative drugs For the treatment of Borderline Personality Disorder (BPD) and Attention Deficit Hyperactivity disorder (ADHD). Partners - Oryzon Genomics
The Teófilo Hernando Foundation (FTH), CRO in Spain and Portugal, supports a clinical stud... 05/07/2024 Healthcare Access to innovation The participation of two of the participating sites in Spain, Hospital Universitario de Toledo and Hospital... Partners - Fundación Teófilo Hernando (FTH)
Biotechnology: A “Key” Sector in the New 2024-2029 Agenda of the European Council 05/07/2024 Healthcare Agrifood Industrial biotechnology The agenda also emphasizes the need to promote research and innovation, as well as public procurement tools, in the... AseBio
Almirall and the Centre for Genomic Regulation (CRG) Advance Research on Atopic Dermatitis 02/07/2024 Healthcare Access to innovation Rare diseases The research objectives of this collaboration include the characterization of experimental models of AD to identity... Partners - Almirall
Biobide at the 51st Annual Meeting of the Japanese Society of Toxicology 02/07/2024 Healthcare Climate change Agrifood Industrial biotechnology International Corporate Don't miss us at the 51st Annual Meeting of the Japanese Society of Toxicology! Partners - Biotechnology Assets
BCN HEALTH publishes a study evaluating the use of resources and medical costs of septic a... 01/07/2024 Healthcare Rare diseases The objective of this study was to review the characteristics of patients admitted with septic arthritis in Spanish... Partners - BCN Health
Augustine Therapeutics raises EUR 17 million in a series a first closing to advance lead c... 01/07/2024 Healthcare Access to innovation Financing Proceeds will advance lead candidate AGT100216, a peripherally restricted and selective HDAC6 inhibitor, into a first-in... Partners - Asabys Partners
